Pharmacielo Stock Total Debt
| PCLO Stock | CAD 0.09 0.01 13.33% |
Pharmacielo fundamentals help investors to digest information that contributes to Pharmacielo's financial success or failures. It also enables traders to predict the movement of Pharmacielo Stock. The fundamental analysis module provides a way to measure Pharmacielo's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pharmacielo stock.
Total Debt To Capitalization is likely to climb to 1.16 in 2024. Pharmacielo | Total Debt |
Pharmacielo Company Total Debt Analysis
Pharmacielo's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Pharmacielo Total Debt | 15.71 M |
Most of Pharmacielo's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharmacielo is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Pharmacielo Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Pharmacielo is extremely important. It helps to project a fair market value of Pharmacielo Stock properly, considering its historical fundamentals such as Total Debt. Since Pharmacielo's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pharmacielo's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pharmacielo's interrelated accounts and indicators.
Click cells to compare fundamentals
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Pharmacielo Net Debt
Net Debt |
|
Based on the latest financial disclosure, Pharmacielo has a Total Debt of 15.71 M. This is 99.43% lower than that of the Pharmaceuticals sector and 99.48% lower than that of the Health Care industry. The total debt for all Canada stocks is 99.7% higher than that of the company.
Pharmacielo Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pharmacielo's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pharmacielo could also be used in its relative valuation, which is a method of valuing Pharmacielo by comparing valuation metrics of similar companies.Pharmacielo is currently under evaluation in total debt category among its peers.
Pharmacielo Fundamentals
| Return On Equity | -30.13 | ||||
| Return On Asset | -0.2 | ||||
| Operating Margin | (2.12) % | ||||
| Current Valuation | 32.83 M | ||||
| Shares Outstanding | 169.74 M | ||||
| Shares Owned By Insiders | 8.43 % | ||||
| Shares Owned By Institutions | 4.58 % | ||||
| Number Of Shares Shorted | 28.63 K | ||||
| Price To Book | 9.48 X | ||||
| Price To Sales | 7.86 X | ||||
| Revenue | 1.54 M | ||||
| Gross Profit | (4.17 M) | ||||
| EBITDA | (7.56 M) | ||||
| Net Income | (16.3 M) | ||||
| Cash And Equivalents | 33.46 M | ||||
| Cash Per Share | 0.34 X | ||||
| Total Debt | 15.71 M | ||||
| Debt To Equity | 2.70 % | ||||
| Current Ratio | 7.36 X | ||||
| Book Value Per Share | (0.03) X | ||||
| Cash Flow From Operations | (5.15 M) | ||||
| Short Ratio | 0.11 X | ||||
| Earnings Per Share | (0.08) X | ||||
| Target Price | 2.5 | ||||
| Beta | 2.39 | ||||
| Market Capitalization | 12.73 M | ||||
| Total Asset | 22.29 M | ||||
| Retained Earnings | (198.71 M) | ||||
| Working Capital | (18.09 M) | ||||
| Net Asset | 22.29 M |
About Pharmacielo Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharmacielo's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmacielo using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmacielo based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pharmacielo Stock Analysis
When running Pharmacielo's price analysis, check to measure Pharmacielo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmacielo is operating at the current time. Most of Pharmacielo's value examination focuses on studying past and present price action to predict the probability of Pharmacielo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmacielo's price. Additionally, you may evaluate how the addition of Pharmacielo to your portfolios can decrease your overall portfolio volatility.